Session Information
2006 Midyear Clinical Meeting
Click here to go to the previous page
Debating the Use of Intensive Insulin Therapy in the ICU
Track:
Sessions
Program Code: 235-L01
Date: Tuesday, December 5, 2006
Time: 9:00 AM to 11:00 AM
Location:
213C (CC)
MODERATOR:
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
SPEAKER(S):
Robert MacLaren, Pharm.D., FCCP, Assistant Professor, School of Pharmacy, University of Colorado, Denver, Colorado
A Review of the Evidence and a Case-Based Pro/Con Debate on Glycemic Control in Different ICU Populations (PI-107)
Allycia M. Natavio, Pharm.D., Clinical Specialist, Surgical Intensive Care Unit, William Beaumont Hospital, Royal Oak, MI
A Review of the Evidence and a Case-Based Pro/Con Debate on Glycemic Control in Different ICU Populations (PI-107)
A Review of the Evidence and a Case-Based Pro/Con Debate on Glycemic Control in Different ICU Populations (PI-107)
Description
Learning Objectives: Describe clinical trials assessing intensive insulin therapy in the ICU. Explain the limitations of currently available data on intensive insulin therapy in the ICU. Explain how the current published data should influence the practice of glucose control in ICU patients.